Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoThe Swiss pharmaceutical company’s drug adalimumab, for the treatment of autoimmune diseases, is likely to gain better-than-expected market sharedue to...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
Morningstar· 2 days agoPreclinical data from the next generation eyedrop platform to be unveiled for the first time at ARVO 2024DAEJEON, South Korea, April 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 6 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
